Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About

Trending Topics

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni

    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor & Employment
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations

    Industries

    View All

    • Cannabis
    • Consumer
    • Energy
    • Entertainment
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Non Profit
    • Real Estate
    • Technology

    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    1. Home
    2. Insights
    3. Articles
    4. The WHO's principled Ethics and Governance of Artificial Intelligence for HealthArticles

    Article

    The WHO's principled Ethics and Governance of Artificial Intelligence for Health

    July 14, 2021

    Share

    By Vincent Capati and Daniel Schwartz

    The World Health Organization recently published its guidance on Ethics & Governance of Artificial Intelligence for Health

    The World Health Organization recently published its guidance on Ethics & Governance of Artificial Intelligence for Health. Recognizing AI’s potential and current utilization in public health and medicine, the WHO cautions “ethical considerations and human rights must be placed at the cent[er] of the design, development, and deployment of AI technologies for health.” Id. at v.

    The WHO identifies six principles “used as a basis for governments, technology developers, companies, civil society[,] and inter-governmental organizations to adopt ethical approaches to appropriate use of AI for health.” Id. at xii. Those principles are as follows:

    • Protecting human autonomy;
    • Promoting human well-being and safety and the public interest;
    • Ensuring transparency, explainability, and intelligibility;
    • Fostering responsibility and accountability;
    • Ensuring inclusiveness and equity; and
    • Promoting AI that is responsive and sustainable.

    The report further identifies a non-comprehensive classification and examples of AI technologies for health as well as proposed legal frameworks. AI applications include diagnostics, clinical care, health research, drug development, health system management and planning, public health and surveillance, and outbreak response. Id. at 6–16. “ While AI may not replace clinical decision-making, it could improve decisions made by clinicians.” Id. at 16. And any framework governing such AI application must protect human rights. Id. at 17. For example, data protection ensures privacy and a person's ability to opt out of any automated process, consistent with informed consent. Id. at 19, 21. And more specifically, the WHO proposes a regulatory framework that includes “ documentation and transparency, risk management and the life-cycle approach, data quality, analytical and clinical validation, engagement and collaboration, and privacy and data protection.” Id. at 22.

    Of course, the United States by congressional activity and by executive order has already made—and continues to make—great strides in facilitating AI research, development, use, and oversight. Nixon Peabody will continue to monitor legislative developments and provide practical considerations as AI-focused bills are debated or passed into law and executive orders are issued.

    Artificial IntelligenceHealthcare

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • © 2023 Nixon Peabody. All rights reserved
    • Privacy Policy
    • Terms of Use
    • Statement of Client Rights
    • Supplier Diversity Program
    • Nixon Peabody International LLC
    • PAL